Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009695
Filing Date
2015-11-05
Accepted
2015-11-05 16:37:11
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20150930.htm 10-Q 1548162
2 EX-10.1 aldr-ex101_332.htm EX-10.1 10926
3 EX-31.1 aldr-ex311_7.htm EX-31.1 12669
4 EX-31.2 aldr-ex312_6.htm EX-31.2 12665
5 EX-32.1 aldr-ex321_8.htm EX-32.1 8618
  Complete submission text file 0001564590-15-009695.txt   4118308

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aldr-20150930.xml EX-101.INS 789369
7 XBRL TAXONOMY EXTENSION SCHEMA aldr-20150930.xsd EX-101.SCH 20608
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20150930_cal.xml EX-101.CAL 35407
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20150930_def.xml EX-101.DEF 53428
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20150930_lab.xml EX-101.LAB 185619
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20150930_pre.xml EX-101.PRE 130712
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 151201255
SIC: 2834 Pharmaceutical Preparations